AzTrials
AzTrials

Substance Use Disorder (SUD)POPCORNNCT07700407

Preventing Overdose and Promoting Recovery Through Court Navigation

A study testing CourtConnect and Information Only in people with Substance Use Disorder (SUD), run by RTI International at 2 sites in United States.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

This project is a hybrid type I clinical trial to assess the effectiveness and implementation determinants of a peer-led court navigation program for people who use drugs and are passing through county courthouses. Read more about this study

Who is it for?
Ages 18 to 100 years
Conditions the study is for
Substance Use Disorder (SUD)
What is being tested?
CourtConnect and Information Only
Could I receive a placebo?
No, everyone receives an active treatment
How many people
600 participants
Where
2 sitesUnited States
Study dates
Oct 2026to May 2030
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 100 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Aged 18 years or older
  • Current resident of Indiana
  • Able to complete study procedures in English
  • Meets at least one of the following criteria: used heroin, fentanyl, methamphetamine, or cocaine in the past 12 months; is interested in resources or treatment for a substance use disorder; or experienced an opioid-related overdose in the past 12 months

Who cannot join

  • Has been sentenced to incarceration in jail or prison for the next 12 months

Trial locations and contacts

2 sites in 1 country. Contact the study team or a site near you to ask about taking part.

Bradley Ray, PhD contact

919-324-5492

bradleyray@rti.org

Cari Megerian, MPH contact

415-412-0830

cmegerian@rti.org

United States2 sites
  • RTI International

    Research Triangle Park, North Carolina, 27709

    Bradley Ray, PhD, 919-324-5492, bradleyray@rti.org

    Cari Megerian, MPH, 415-412-0830, cmegerian@rti.org

  • St. Joseph County Courthouse 1

    South Bend, Indiana, 46601

    Bradley Ray, PhD, 919-324-5492, bradleyray@rti.org

    Cari Megerian, MPH, 415-412-0830, cmegerian@rti.org

Other trials in United States

About this study

Official title: Hybrid Type I Trial of a Peer-Led Court Navigation Program to Improve Substance Use Disorder Treatment Receipt and Reduce Overdose and Incarceration Among People Passing Through Courthouses

This project is a hybrid type I clinical trial to assess the effectiveness and implementation determinants of a peer-led court navigation program for people who use drugs and are passing through county courthouses. Courthouses are a common point of contact for people with behavioral health needs, but outside of specialty court models, they remain underexplored as a setting for connecting people to substance use disorder treatment and related services. This study will test whether court navigation led by peer recovery specialists can increase receipt of substance use disorder treatment and reduce overdose and incarceration. Peer court navigators will meet with participants in courthouse settings, assess their needs, provide information and referrals, and offer follow-up support for up to 3 months. Peer recovery specialists, who have lived experience with substance use recovery, are increasingly being integrated into criminal legal and community-based settings; however, peer-led court navigation remains an innovative and understudied approach.

Being tested
CourtConnect, Information Only
Keywords
court navigation, peer recovery coach, substance use disorder treatment, fatal overdose, nonfatal overdose, incarceration, jail booking, prison entry, criminal legal system
Medical subject headings
Substance-Related Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • CourtConnectBehavioural

    CourtConnect connects individuals in courthouses with peer court navigators who provide information, referrals, and support to address substance use disorder treatment needs and related health and social needs. Navigation begins in the courthouse and continues in the community through follow-up support for up to 3 months.

  • Information OnlyOther

    Participants assigned to the information-only group receive information about health and social services in the community from a non-peer research assistant. They do not receive peer court navigation or follow-up support from a peer court navigator.

Study groups in NCT07700407
Study groupRoleWhat they receive
Peer court navigationExperimentalCourtConnect is the intervention. It connects individuals in courthouses with peer court navigators who provide information, referrals, and support to address substance use disorder treatment needs and related health and social needs. Navigation begins in the courthouse and continues in the community through follow-up support for up to 3 months.
Receives: Behavioral: CourtConnect
Information onlyActive comparatorParticipants assigned to the information-only group receive information about health and social services in the community from a non-peer research assistant. They do not receive peer court navigation or follow-up support from a peer court navigator.
Receives: Other: Information Only

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Administratively documented substance use disorder treatment engagement

    This participant-level outcome will indicate whether a participant has any administratively documented substance use disorder treatment engagement within 90 days after baseline. Treatment engagement will be determined from linked state administrative records, including Medicaid claims for substance use disorder treatment services and prescription drug monitoring program records showing dispensed medications used to treat substance use disorder. For participants without administratively documented substance use disorder treatment during the 90 days before baseline, a qualifying post-baseline record will be classified as treatment initiation. For participants with administratively documented substance use disorder treatment during the 90 days before baseline, a qualifying post-baseline record will be classified as continued treatment engagement. The outcome will be reported as the proportion of participants in each study arm with administratively documented treatment engagement.

    Measured: 90 days after baseline

Secondary outcomes (2)
  1. Number of participants with a fatal or nonfatal overdose

    Fatal and nonfatal overdose will be measured using statewide vital records and emergency medical records from ambulance services and hospital emergency departments. Participants will be classified as having experienced an overdose if records show a fatal overdose or an encounter for a nonfatal overdose during the 12 months after baseline.

    Measured: 12 months after baseline

  2. Number of participants with a jail booking or prison entry

    Incarceration through jail booking or prison entry will be measured using statewide criminal legal records. Participants will be classified as having experienced incarceration if records show a booking into a jail facility or entry into the state prison system during the 12 months after baseline.

    Measured: 12 months after baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Jul 2026
  2. Study startOct 2026 (estimated)
  3. Primary completionDec 2028 (estimated)
  4. Study completionMay 2030 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
600 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07700407
Sponsor's protocol ID
R01DA064492
Other IDs
R01DA064492
Acronym
POPCORN
Status last verified
Jul 2026
First submitted
3 Jul 2026
Last updated
14 Jul 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: The investigators will enroll 600 subjects over 24 months with 12 months of follow-up data by linking administrative records (e.g., prescription fills, emergency department/emergency medical services encounters, mortality, arrests/jail bookings) to survey contents that will include demographics, substance use disorder and treatment history, criminal legal system involvement, social constructs (self-efficacy, motivation, stigma), and harmonized measures. The National Institutes of Health requires that the study team release study data. The investigators will preserve and share de-identified survey datasets (with codebooks), and project documentation (protocols, instruments); derived variables from linked administrative data will be shared, while raw state administrative source files obtained under data use agreements will not be shared. The publicly released scientific data will include only fully de-identified data.

Questions about this trial

What is this clinical trial studying?

A study testing CourtConnect and Information Only in people with Substance Use Disorder (SUD), run by RTI International at 2 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 14 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Bradley Ray, PhD (919-324-5492, bradleyray@rti.org), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Administratively documented substance use disorder treatment engagement (time frame: 90 days after baseline). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Jul 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in